Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures branded generic drugs and trades in bioscience products and medical equipment.
Regenix Drugs Limited, is an unlisted public company incorporated on 10 May, 2007. It is classified as a public limited company and is located in , . It's authorized share capital is INR 21.55 cr and the total paid-up capital is INR 18.08 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Arvind Akshay | 05355266 | 3 years |
Whole-time Director | Balaji Ramamurthy
Shareholder
|
09350272 | 3 years |
Director | Malathi Ramamurthy
Shareholder
|
01965601 | 13 years |
Director | Govindarajan Venkatakrishna
Shareholder
|
02159359 | 15 years |
Director | Gunasekaran Raju
Shareholder
|
01951733 | 18 years |
Managing Director | Ramamurthy Ayyavuthevar
Shareholder
|
00446203 | 18 years |
Director | Ayyamperumal
Shareholder
|
08545531 | 6 years |
Director | Guhan Ramamurthy
Shareholder
|
09057147 | 4 years |
Whole-time Director | Krishanamoorthy Nirosha | 09056949 | 4 years |
Director | Radhakrishnan Venu Murali
Shareholder
|
02285294 | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 11.7 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.1 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
REGENIX SUPER SPECIALITY LABORATORIES PRIVATE LIMITED | Tamil Nadu | 2011 | ₹ 1.2 Cr |
REGENIX BIOSCIENCES LIMITED | Tamil Nadu | 2006 | ₹ 14.4 Cr |
Read more
The incorporation date of REGENIX DRUGS LIMITED is 10 May, 2007
The authorized share capital of REGENIX DRUGS LIMITED is INR ₹ 21.6 Cr.
The paid-up capital of REGENIX DRUGS LIMITED is INR ₹ 18.1 Cr.
The registered address of REGENIX DRUGS LIMITED is JAMAL SONU TERRACE, 42/1 LOGANATHAN NAGAR FIRST STREET, 100 FEET ROAD, CHOOLAIMEDU, CHENNAI, Tamil Nadu, India, 600094 - 600094
The CIN number of REGENIX DRUGS LIMITED is U24232TN2007PLC063446.